| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |